Building a leading one-stop ambulatory cancer center
SIAMH has successfully registered the offer document, launched an IPO and raised US$19.5 million.
SIAMH is a one-stop outpatient diagnostics and treatment center for cancer, neurogenerative and cardiovascular diseases in Singapore.
Oaklins’ team in Singapore acted as sponsor, issue manager, underwriter and placement agent in this transaction.
Talk to the deal team
Related deals
Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market
Doverie United Holding has successfully completed the sale of United Health Insurance Fund Doverie (Doverie) to Generali CEE Holding.
Learn moreDimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn more